Regeneron Pharmaceuticals, Inc. (REGN) Insider Ownership

Historic Ownership Trends

According to recent filings covering the 90 days ending December 12, 2025, the three most significant insider holders at Regeneron Pharmaceuticals are Bd. Co Chair And President & CEO Leonard S Schleifer (506.86K shares), EVP Research Andrew J Murphy (52.06K shares), EVP General Counsel And Secret Joseph J Larosa (29.52K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares Report Date
P Roy Vagelos 438,071 24 Mar, 2023
George Yancopoulos Bd. Co Chair And President & Cso 366,508 11 Dec, 2025
Leonard S Schleifer Bd. Co Chair And President & CEO 254,508 11 Dec, 2025
Neil Stahl EVP Research And Development 53,434 18 Dec, 2024
Andrew J Murphy EVP Research 47,833 11 Dec, 2025
Joseph J Larosa EVP General Counsel And Secret 29,517 09 Dec, 2025
George L Sing 28,828 03 Jan, 2025
Robert E Landry EVP Finance Cfo 23,693 06 Feb, 2024
Plew Daniel P Van EVP & General Mgr And Industrial 21,673 11 Dec, 2025
Christopher R. Fenimore EVP Finance Cfo 18,325 09 Dec, 2025
Arthur F Ryan 17,748 06 Jan, 2025
Marion Mccourt EVP Commercial 14,349 11 Dec, 2025
Michael S Brown 7,710 06 Jan, 2025
Joseph L Goldstein 6,548 06 Jan, 2025
Jason Pitofsky VP Controller 5,487 09 Dec, 2025
Christine A Poon 5,064 31 Oct, 2025
Marc Tessier-Lavigne 2,434 05 Jan, 2023
N Anthony Coles 1,559 06 Jan, 2025
Bonnie L Bassler 1,548 24 Nov, 2025
Huda Y Zoghbi 1,548 06 Jan, 2025
Craig B. Thompson 620 06 Jan, 2025
David P Schenkein 448 06 Jan, 2025
Kathryn Guarini 448 06 Jan, 2025

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
09 Dec, 2025 Plew Daniel P Van Common Stock D 2,552 $701.51 21,673 D F
09 Dec, 2025 Marion Mccourt Common Stock D 1,021 $701.51 14,349 D F
09 Dec, 2025 Andrew J Murphy Common Stock D 4,229 $701.51 47,833 D F
09 Dec, 2025 George Yancopoulos Common Stock A 146,815 $555.67 442,334 D M
09 Dec, 2025 Leonard S Schleifer Common Stock A 172,723 $555.67 369,668 D M
09 Dec, 2025 George Yancopoulos Common Stock D 131,874 $701.51 310,460 D F
09 Dec, 2025 Leonard S Schleifer Common Stock D 155,145 $701.51 214,523 D F
05 Dec, 2025 Joseph J Larosa Common Stock A 2,476 $0.00 30,913 D A
05 Dec, 2025 Christopher R. Fenimore Common Stock A 3,027 $0.00 19,292 D A
05 Dec, 2025 Jason Pitofsky Common Stock A 2,064 $0.00 6,297 D A
05 Dec, 2025 Andrew J Murphy Common Stock A 3,715 $0.00 53,761 D A
05 Dec, 2025 Plew Daniel P Van Common Stock A 3,715 $0.00 26,131 D A
05 Dec, 2025 Marion Mccourt Common Stock A 2,476 $0.00 16,706 D A
08 Dec, 2025 Joseph J Larosa Common Stock D 1,396 $712.94 29,517 D F
08 Dec, 2025 Plew Daniel P Van Common Stock D 1,906 $712.94 24,225 D F
08 Dec, 2025 Marion Mccourt Common Stock D 1,336 $712.94 15,370 D F
08 Dec, 2025 Andrew J Murphy Common Stock D 1,699 $712.94 52,062 D F
08 Dec, 2025 Christopher R. Fenimore Common Stock D 992 $712.94 18,300 D F
08 Dec, 2025 Jason Pitofsky Common Stock D 989 $712.94 5,308 D F
20 Nov, 2025 Bonnie L Bassler Common Stock A 760 $371.40 2,308 D M